Patents by Inventor Satoru Iwanami

Satoru Iwanami has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NUCLEIC ACID AMPLIFICATION METHOD
    Publication number: 20220145360
    Abstract: The invention provides a reciprocal-flow-type nucleic acid amplification method performing thermal cycling by reciprocating a sample liquid between a denaturation temperature zone and an elongation-annealing temperature zone with a connected microchannel including at least a curved channel corresponding to the denaturation temperature zone, a curved channel corresponding to the elongation-annealing temperature zone, a linear or curved intermediate channel that connects the aforementioned curved channels, and a connector to connect to a liquid delivery mechanism for enabling movement of the sample liquid.
    Type: Application
    Filed: March 13, 2020
    Publication date: May 12, 2022
    Applicants: NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY, KYORIN PHARMACEUTICAL CO., LTD.
    Inventors: Hidenori NAGAI, Satoru IWANAMI
  • Diaryl ether derivative, addition salt thereof, and immunosuppressant
    Patent number: 6963012
    Abstract: The present invention provides diaryl ether derivatives that exhibit significant immunosuppressive effects with less side effects. The diaryl derivatives of the present invention are represented by the following general formula (1): one example is 2-amino-2-[4-(3-benzyloxyphenoxy)-2-chlorophenyl]propyl-1,3-propanediol.
    Type: Grant
    Filed: September 25, 2002
    Date of Patent: November 8, 2005
    Assignee: Kyorin Pharmaceutical Co., Ltd.
    Inventors: Yasushi Kohno, Naoki Ando, Takahiro Tanase, Kazuhiko Kuriyama, Satoru Iwanami, Shinji Kudou
  • Diaryl sulfide derivative, addition salt thereof, and immunosuppressant
    Patent number: 6960692
    Abstract: The present invention provides diaryl sulfide derivatives that exhibit significant immunosuppressive effects with less side effects. The diaryl derivatives of the present invention are represented by the following general formula (1): One example is 2-amino-2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]propyl-1,3-propanediol.
    Type: Grant
    Filed: September 25, 2002
    Date of Patent: November 1, 2005
    Assignee: Kyorin Pharmaceutical Co., Ltd.
    Inventors: Yasushi Kohno, Naoki Ando, Kazuhiko Kuriyama, Satoru Iwanami, Shinji Kudou
  • Diaryl sulfide derivative, addition salt thereof, and immunosuppressant
    Publication number: 20040254222
    Abstract: The present invention provides diaryl sulfide derivatives that exhibit significant immunosuppressive effects with less side effects.
    Type: Application
    Filed: March 17, 2004
    Publication date: December 16, 2004
    Inventors: Yasushi Kohno, Naoki Ando, Kazuhiko Kuriyama, Satoru Iwanami, Shinji Kudou
  • Diaryl ether derivative, addition salt thereof, and immunosuppressant
    Publication number: 20040242654
    Abstract: The present invention provides diaryl ether derivatives that exhibit significant immunosuppressive effects with less side effects.
    Type: Application
    Filed: March 22, 2004
    Publication date: December 2, 2004
    Inventors: Yasushi Kohno, Naoki Ando, Takahiro Tanase, Kazuhiko Kuriyama, Satoru Iwanami, Shinji Kudou